Drug nameN-(4-Hydroxyphenyl)All-Trans Retinamide
DescriptionA synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent. [PubChem]
DrugBankPrimary Accession Number: DB03922
DINNot available
TypeExperimental, Small Molecule
IndicationNot available
Mechanism of ActionNot available
AbsorptionNot available
ToxicityNot available
Protein BindingNot available
Interactions
RXListNot available
KEGGdrug: Not available / compound: Not Available
PubChemcompound: 5288209 / substance: 7887469
PharmGKBNot available
Metabolizing Enzymes
NameGeneEntrezIDUniprotSNP
Target
NameGeneEntrezIDSwissprotSNP
Plasma retinol-binding proteinRBP45950RETBP_BOVINrs34812400 rs11546956 rs11546955
FilesDB03922.mol | pdb_7111481125473-0.pdb | sdf_3259024814996-0.sdf |
Smilesisomeric:
CC(C=CC1=C(C)CCCC1(C)C)=C/C=C/C(C)=C/C(=O)NC1=CC=C(O)C=C1
canonical:
CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)NC1=CC=C(O)C=C1

© 2010-2020 All rights reserved. King Abdullah University of Science and Technology, All rights reserved